Skip to main content

Casdin Capital — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

95
Companies
$6.8B
Total invested
$71.7M
Avg. check
22
Industries
Biotechnology 20Health Care 12Therapeutics 7Life Science 7Genetics 6Biopharma 6+16 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 95
Function Oncology
April 2023

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

Biotechnology · San Diego$28.0M Series A
Generation Bio
March 2023

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Biotechnology · Cambridge$76.0M Post-IPO Equity
Flare Therapeutics
March 2023

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Biopharma · Cambridge$123.0M Series B
iVexSol
January 2023

IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.

Manufacturing · Lexington$23.8M Series A
Vector Biomed
December 2022

Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.

Machinery Manufacturing · Gaithersburg$15.0M Venture - Series Unknown
Invetx
May 2022

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

Biopharma · Boston$60.5M Series B
Celsius Therapeutics
March 2022

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Biotechnology · Cambridge$83.0M Series B
InnoSIGN
March 2022

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.

Biotechnology · Eindhoven$8.1M Series A
Creyon Bio
March 2022

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Biotechnology · San Diego$40.0M Series A
Basilard BioTech
February 2022

Basilard BioTech features a technology platform that transforms the rapidly growing cell-based therapies market.

Biopharma · CaliforniaSeed
ONI
December 2021

ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.

Biotechnology · Oxford$75.0M Series B
Depixus
December 2021

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

Biotechnology · Courbevoie$34.5M Series A
Exai Bio
December 2021

Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.

Biotechnology · Palo Alto$67.5M Series A
Variant Bio
November 2021

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Biotechnology · Seattle$105.0M Series B
Cedilla Therapeutics
October 2021

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

Biotechnology · Cambridge$25.0M Series B
Loop Medical
October 2021

Loop Medical develops an easy and painless blood collection technology making it accessible to all.

Health Care · Lausanne$6.4M Series A
Exo Therapeutics
October 2021

Exo Therapeutics is a small molecule drug discovery and development company.

Biotechnology · Cambridge$78.0M Series B
Foghorn Therapeutics
January 2026

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Biopharma · Cambridge$50.0M Post Ipo Equity
Contineum Therapeutics
December 2025

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

Biotechnology · San Diego$99.2M Post Ipo Equity
4D Molecular Therapeutics
November 2025

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Biotechnology · Emeryville$100.0M Post Ipo Equity
Octave
October 2025

Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.

Biotechnology · Menlo ParkGrant
CANbridge Pharmaceuticals
August 2025

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Biotechnology · Beijing$12.7M Post Ipo Equity
BBOT
August 2025

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.

Biopharma · Palo Alto$261.0M Post Ipo Equity
Absci
July 2025

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Artificial Intelligence (AI) · Vancouver$50.0M Post Ipo Equity

Where Casdin Capital invests

Biotechnology20
Health Care12
Therapeutics7
Life Science7
Genetics6
Biopharma6

About Casdin Capital's portfolio

How many companies has Casdin Capital invested in?▸

Casdin Capital has invested in 95 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Casdin Capital invest in?▸

Casdin Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Genetics. The firm invests across 22 different industry categories.

What is Casdin Capital's largest investment?▸

Among tracked funding rounds, BBOT received $261.0M in a Post Ipo Equity round. Casdin Capital's total known invested capital is $6.8B.

What is the average investment size for Casdin Capital?▸

Casdin Capital's average investment size is $71.7M across its portfolio of 95 companies.

What are Casdin Capital's most recent investments?▸

Recent Casdin Capital portfolio additions include Function Oncology, Generation Bio, Flare Therapeutics, iVexSol, Vector Biomed. These companies were founded in 2020 or later.

Reach the founders behind these 95 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →